The European Commission has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer (NSCLC). The
Tag "Drug"
The Irish Government risks losing out on hundreds of millions of euro in savings on its drug bill because of the failure to buy generic alternatives to expensive branded drugs.
Advertisements
